Gerresheimer reports new Goldman Sachs voting stake disclosure, shares on Xetra tracked by analysts
23.06.2026 - 09:37:25 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 09:35.
Gerresheimer (DE000A0LD6E6) disclosed a new voting rights notification from Goldman Sachs after the US investment bank exceeded the 10 percent threshold in the company, according to a filing distributed via EQS on June 22, 2026. The MDAX-listed pharma packaging specialist trades on Xetra and remains actively covered by international analysts.
What the Goldman Sachs filing says
According to the EQS voting rights announcement, Goldman Sachs Group, Inc. notified Gerresheimer on June 12, 2026 that its total voting rights position reached and exceeded the 10 percent threshold set under sections 33 and 34 of the German Securities Trading Act (WpHG). The notification details both direct and attributable holdings via subsidiaries and financial instruments.
The company distributed the notice to the market on June 22, 2026 in line with regulatory requirements for German issuers. Voting rights disclosures of this size are closely watched by investors as they indicate a significant institutional position, especially when they involve a global investment bank such as Goldman Sachs.
Analyst coverage and consensus picture
Gerresheimer is part of the MDAX and widely followed by European brokerages that track German mid caps alongside peers such as Sartorius and Stevanato in the medical and packaging space. Market data platforms show a balanced mix of Buy and Hold recommendations and an average 12-month price target that implies moderate upside from current levels, according to an overview on MarketScreener.
Analysts typically highlight the company’s exposure to structurally growing end-markets such as injectable drugs, biologics and high-value glass vials. At the same time, they monitor input cost trends, contract structures and capital expenditure intensity when assessing Gerresheimer’s profitability profile and leverage in comparison with sector peers in Europe and North America.
All news and analysis on the Gerresheimer shares
On the ad-hoc-news.de topic page investors find further disclosures, analyst views and price data on Gerresheimer in one place.
How Gerresheimer earns its money
Gerresheimer generates revenue primarily by producing specialty glass and plastic packaging for the pharmaceutical and healthcare industries, including prefillable syringes, insulin pens and high-value vials. The company also supplies packaging solutions for cosmetics and other healthcare-related products to global brand owners.
Where the shares trade today
The Gerresheimer shares (DE000A0LD6E6) trade on Xetra at 101.20 euros as of 2026-06-23, 09:30, based on data from Deutsche Börse.
Key data on the Gerresheimer shares
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Trading venue: Xetra
- Price (as of 2026-06-23, 09:30): 101.20 EUR
- Market cap: 3.2 billion EUR (as of 2026-06-23)
- Sector / industry: Health care equipment & supplies / pharmaceutical packaging
- Index membership: MDAX, SDAX
- Next earnings date: 2026-07-11
This text is for informational purposes only and does not constitute investment advice, an offer or a solicitation to buy or sell any financial instrument. Past performance is not a reliable indicator of future results.
